Scopus BioPharma Inc. (SCPS) DCF Valuation

Scopus BioPharma Inc. (SCPS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Scopus BioPharma Inc. (SCPS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (SCPS) DCF Calculator! Equipped with up-to-date Scopus BioPharma Inc. data and customizable assumptions, this tool empowers you to forecast, evaluate, and value (SCPS) just like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2018		 AY2
2019		 AY3
2020		 AY4
2021		 AY5
2022		 FY1
2023		 FY2
2024		 FY3
2025		 FY4
2026		 FY5
2027
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -.7 -2.7 -10.2 -27.6 -11.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -.8 -2.7 -10.2 -27.6 -11.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 .0 1.8 7.9 .1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .7 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.89672 0.89672 0.89672 0.89672 0.89672 0.89672 0.89672 0.89672 0.89672 0.89672
EBITAT -.8 -2.7 -10.8 -28.4 -11.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.7 -3.4 -10.1 -28.4 -11.6 .0 .0 .0 .0 .0
WACC, % 186.94 186.94 186.94 186.94 186.94 186.94 186.94 186.94 186.94 186.94
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt 0
Equity Value 0
Diluted Shares Outstanding, MM 21
Equity Value Per Share 0.01

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Scopus BioPharma Inc.’s (SCPS) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model designed to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical data and future forecasts for Scopus BioPharma Inc. (SCPS).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic refresh of DCF, Net Present Value (NPV), and cash flow analysis.
  • User-Friendly Dashboard: Clear and informative charts and summaries to help visualize your valuation outcomes.
  • Designed for All Skill Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the pre-built Excel file featuring Scopus BioPharma Inc.'s (SCPS) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly compare results.
  • Make Decisions: Leverage the valuation findings to inform your investment strategy.

Why Choose This Calculator for Scopus BioPharma Inc. (SCPS)?

  • Designed for Industry Experts: A sophisticated tool tailored for biopharma analysts, investors, and strategic planners.
  • Comprehensive Data: Scopus BioPharma’s historical and projected financials are preloaded for reliable analysis.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance ensures a seamless experience throughout the calculation process.

Who Should Use Scopus BioPharma Inc. (SCPS)?

  • Investors: Gain insights into innovative biopharmaceutical solutions backed by extensive research.
  • Healthcare Analysts: Utilize comprehensive data to assess market potential and company performance.
  • Consultants: Tailor presentations and reports with up-to-date information on cutting-edge therapies.
  • Biotech Enthusiasts: Explore the latest advancements in drug development and therapeutic strategies.
  • Educators and Students: Leverage real-world case studies to enhance learning in biotechnology and finance.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Scopus BioPharma Inc. (SCPS) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models demonstrating intrinsic value with comprehensive calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Scopus BioPharma Inc. (SCPS).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to easily analyze results.

No products were found matching.